Related Experiment Videos

Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide

R X Xu1, J M Word, D G Davis

  • 1Molecular Sciences Division, Glaxo Research Institute, Research Triangle Park, North Carolina 27709.

Biochemistry
|February 21, 1995
PubMed

Insights

Nuclear magnetic resonance (NMR) structures reveal the src SH2 domain complexed with a phosphopeptide. This study elucidates molecular interactions crucial for signal transduction and cancer development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biophysics

Background:

  • Human pp60c-src tyrosine kinase is involved in cytosolic signal transduction.
  • Its SH2 domain mediates interactions critical for cellular signaling.
  • Dysregulation of src kinase is linked to breast and colon cancer development.

Purpose of the Study:

  • To determine the solution structure of the src SH2 domain complexed with a high-affinity phosphopeptide.
  • To elucidate the molecular conformation and interactions of the src SH2 domain in solution.

Main Methods:

  • High-resolution nuclear magnetic resonance (NMR) spectroscopy was employed.
  • A family of 23 structures was generated using distance geometry and simulated annealing.
  • The study utilized multifrequency, multidimensional, and isotope-filtered NMR data.

Main Results:

  • The src SH2 domain adopts a conformation with three antiparallel beta-strands and flanking alpha-helices.
  • The phosphopeptide ligand binds in an extended conformation, with key residues interacting with protein binding pockets.
  • Solution structures revealed differences in specific residue interactions compared to crystal structures, potentially due to dynamics.

Conclusions:

  • The determined NMR structures provide detailed insights into src SH2 domain-ligand interactions in solution.
  • Observed discrepancies with crystal structures highlight the importance of considering solution dynamics.
  • Understanding these interactions is vital for comprehending signal transduction pathways and developing targeted cancer therapies.

Related Concept Videos